August 5, 2010

Generic HIV Drugs Threatened by Stricter Patent Rules

Stricter global intellectual property rules are threatening generic versions of antiretroviral (ARV) treatments manufactured in India and other developing countries, PlusNews reports. Patents for first-line ARVs have expired, making them free to produce, but the newer and more effective drugs are out of reach to less developed nations. A group of nongovernmental organizations has filed a complaint to the United Nations saying patent restrictions are a violation to international rights to health.

To read the PlusNews article, click here.

Search: Patents, ARV, antiretrovirals, India, developing countries, United Nations

Scroll down to comment on this story.